~~<i id='80DFF455F4'><strike id='80DFF455F4'><tt id='80DFF455F4'><pre id='80DFF455F4'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：entertainment 2025-09-29 00:13:30 Page View：412

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： CDC advisory group OKs chikungunya vaccine
Next article： Medicare proposal to cover medical devices draws a mixed reaction

explore

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

FILE-Myanmar'sleaderAungSanSuuKyi,left,attendsthebilateralmeetingwithChinesePresidentXiJinpingatthep

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Children’s Hospital revives plan for pedestrian bridge

ArenderingoftheLongwoodAvenuefootbridgeBostonChildren’sHospitalplanstobuild.Elkus/ManfrediArchitects